Literature DB >> 28628430

Autosomal dominant polycystic kidney disease and the heart and brain.

Vinod Krishnappa1, Poornima Vinod2, Divya Deverakonda3, Rupesh Raina4.   

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) has numerous systemic manifestations and complications. This article gives an overview of hypertension, cardiac complications, and intracranial aneurysms in ADPKD, their pathophysiology, and recent developments in their management.
Copyright © 2017 Cleveland Clinic.

Entities:  

Mesh：

Year:  2017        PMID： 28628430     DOI： 10.3949/ccjm.84a.16107

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN： 0891-1150            Impact factor:   2.321


  9 in total

1.  Polycystin-1 Assembles With Kv Channels to Govern Cardiomyocyte Repolarization and Contractility.

Authors:  Francisco Altamirano; Gabriele G Schiattarella; Kristin M French; Soo Young Kim; Felipe Engelberger; Sergii Kyrychenko; Elisa Villalobos; Dan Tong; Jay W Schneider; Cesar A Ramirez-Sarmiento; Sergio Lavandero; Thomas G Gillette; Joseph A Hill
Journal:  Circulation       Date:  2019-06-21       Impact factor: 29.690

2.  Pericardial Effusion on MRI in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Jin Liu; Kana Fujikura; Hreedi Dev; Sadjad Riyahi; Jon Blumenfeld; Jiwon Kim; Hanna Rennert; Martin R Prince
Journal:  J Clin Med       Date:  2022-02-21       Impact factor: 4.241

Review 3.  The Role of Endothelin and Endothelin Antagonists in Chronic Kidney Disease.

Authors:  Rupesh Raina; Abigail Chauvin; Ronith Chakraborty; Nikhil Nair; Haikoo Shah; Vinod Krishnappa; Kirsten Kusumi
Journal:  Kidney Dis (Basel)       Date:  2019-12-18

4.  Revisiting racial differences in ESRD due to ADPKD in the United States.

Authors:  Erin L Murphy; Feng Dai; Katrina Lehmann Blount; Madeline L Droher; Lauren Liberti; Deidra C Crews; Neera K Dahl
Journal:  BMC Nephrol       Date:  2019-02-14       Impact factor: 2.388

5.  TRPP2 dysfunction decreases ATP-evoked calcium, induces cell aggregation and stimulates proliferation in T lymphocytes.

Authors:  Riccardo Magistroni; Alessandra Mangolini; Sonia Guzzo; Francesca Testa; Mario R Rapanà; Renzo Mignani; Giorgia Russo; Francesco di Virgilio; Gianluca Aguiari
Journal:  BMC Nephrol       Date:  2019-09-13       Impact factor: 2.388

6.  Primary cilia control endothelial permeability by regulating expression and location of junction proteins.

Authors:  Mannekomba R Diagbouga; Sandrine Morel; Anne F Cayron; Julien Haemmerli; Marc Georges; Beerend P Hierck; Eric Allémann; Sylvain Lemeille; Philippe Bijlenga; Brenda R Kwak
Journal:  Cardiovasc Res       Date:  2022-05-06       Impact factor: 13.081

Review 7.  Klotho/FGF23 and Wnt Signaling as Important Players in the Comorbidities Associated with Chronic Kidney Disease.

Authors:  Juan Rafael Muñoz-Castañeda; Cristian Rodelo-Haad; Maria Victoria Pendon-Ruiz de Mier; Alejandro Martin-Malo; Rafael Santamaria; Mariano Rodriguez
Journal:  Toxins (Basel)       Date:  2020-03-16       Impact factor: 4.546

8.  Disease causing property analyzation of variants in 12 Chinese families with polycystic kidney disease.

Authors:  Kexian Dong; Xiaogang Liu; Xueyuan Jia; Huanhuan Miao; Wei Ji; Jie Wu; Yun Huang; Lidan Xu; Xuelong Zhang; Hui Su; Guohua Ji; Peng Liu; Rongwei Guan; Jing Bai; Songbin Fu; Xianli Zhou; Wenjing Sun
Journal:  Mol Genet Genomic Med       Date:  2020-09-24       Impact factor: 2.183

Review 9.  Metabolic Changes in Polycystic Kidney Disease as a Potential Target for Systemic Treatment.

Authors:  Sophie Haumann; Roman-Ulrich Müller; Max C Liebau
Journal:  Int J Mol Sci       Date:  2020-08-24       Impact factor: 5.923
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.